ACOG — Alpha Cognition Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1655923 ·
Last close
$7.92
Market Cap
$174.57M
52W High
$10.14
52W Low
$4.50
ADV30
104,282
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 7,777,002 | 7,294,581 | -6,430,704 | -7,616,727 | 64,001,174 | 37,801,828 | 14,680,466 |
| Jun 2026 | 6,092,974 | 5,701,917 | -7,756,008 | -8,789,740 | 64,519,883 | 41,384,287 | 11,558,134 |
| Mar 2026 | 3,533,798 | 3,262,022 | -8,096,227 | -6,478,018 | 69,248,341 | 54,248,275 | 11,791,836 |
| Dec 2025 | 2,793,076 | 2,540,827 | -7,925,270 | -6,856,306 | 79,730,235 | 66,046,789 | 17,200,060 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,853,299
Investing CF
$-6,228,498
Financing CF
$39,060,874
CapEx
$-6,228,498
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.84
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-112,374,533
Inventory
$6,394,817
Receivables
$5,648,873
ST Investments
—
EBIT TTM
$-29,079,491
Pretax Income TTM
$-23,442,139
Interest Exp TTM
$13,701
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,260,706
EBITDA
$-26,487,652
Free Cash Flow
$-28,530,086
Enterprise Value
$146,340,992
Total Cash
$41,384,288
Total Debt
$0
Shares Out
22,041,337
Trailing EPS
$-1.32
Book Value
$2.87
ROE
-49.5%
ROA
-30.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,220,275 | -22,579,594 | -20,669,875 | 79,730,235 | 17,200,060 | 62,530,175 | -20,380,367 |
| Dec 2024 | 0 | -11,548,636 | -14,788,727 | 50,736,938 | 11,642,111 | 39,094,827 | -7,755,654 |
| Dec 2023 | 0 | -9,617,813 | -13,763,658 | 2,452,170 | 7,155,865 | -4,703,695 | -8,799,565 |
| Dec 2022 | 0 | -13,465,624 | -12,114,698 | 2,950,951 | 4,271,128 | -1,320,177 | -9,241,650 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$15,260,706
NetIncome TTM
$-23,442,138
OpCashFlow TTM
—
Assets (Latest)
$64,519,883
Forward EPS
$-0.56
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $8.60 · call volume: 28 · put volume: 3
Expected Move to 2027-02-19:
±$3.65
(42.44%) —
implied range
$4.95 –
$12.25
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IPHYF | Innate Pharma SA | $168.56M | $1.51 | — |
| PALI | PALISADE BIO, INC. | $181.07M | $1.01 | — |
| ARTV | Artiva Biotherapeutics, Inc. | $190.81M | $3.86 | — |
| CGEN | COMPUGEN LTD | $191.34M | $2.02 | — |
| IKT | Inhibikase Therapeutics, Inc. | $193.57M | $1.38 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Analysts Predict an 119.28% Upside in Alpha Cognition Inc. (ACOG): Here's What You Should Know
2026-11-16 13:55 · Yahoo
Alpha Cognition Announces Publication of U.S. Patent Application for Benzgalantamine for Treating Persistent Post-Concussion Symptoms
2026-11-16 13:30 · Yahoo
Alpha Cognition (ACOG) Q3 2026 Earnings Call Transcript
2026-11-12 02:03 · Yahoo
Alpha Cognition Inc. Common Stock Q3 2026 Earnings Call Summary
2026-11-12 01:24 · Yahoo
What Alpha Cognition (ACOG) Said on Its Q3 Earnings Call
2026-11-11 23:13 · Yahoo
Alpha Cognition Inc. (ACOG) Reports Q3 Loss, Beats Revenue Estimates
2026-11-11 21:20 · Yahoo
Alpha Cognition Inc. Reports Third Quarter 2026 Financial Results and Provides Operational Update
2026-11-11 21:05 · Yahoo
Alpha Cognition Strengthens Its Board of Directors with Appointment of Caren Deardorf
2026-11-09 13:30 · Yahoo
Alpha Cognition to Participate in Upcoming Investor Events
2026-11-06 20:00 · Yahoo
Alpha Cognition to Report Third Quarter 2026 Financial Results and Provide Business Update
2026-11-02 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.